ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
Nikolajxo1
|
576 |
205K |
0 |
03/10/22 |
03/10/22 |
ASX - By Stock
|
576
|
205K
|
0
|
|
ASX - By Stock
|
MSB |
Moneymaker1979 discussion
|
|
Nikolajxo1
|
4 |
1.5K |
0 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
1 |
24/03/21 |
24/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
1 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Short
|
|
Nikolajxo1
|
35 |
10K |
2 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
35
|
10K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Shorters in drugmaker Mesoblast sweat on crucial capital raising
|
|
Nikolajxo1
|
123 |
42K |
3 |
02/03/21 |
02/03/21 |
ASX - By Stock
|
123
|
42K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
Nikolajxo1
|
297 |
100K |
1 |
27/02/21 |
27/02/21 |
ASX - By Stock
|
297
|
100K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
Nikolajxo1
|
297 |
100K |
0 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
297
|
100K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Nikolajxo1
|
272 |
138K |
2 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
138K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Nikolajxo1
|
272 |
138K |
3 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
138K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Nikolajxo1
|
272 |
138K |
3 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
138K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
2 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
3 |
20/02/21 |
20/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Nikolajxo1
|
1.1K |
313K |
3 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
313K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
1 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
1 |
06/02/21 |
06/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
10 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
10K
|
3.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Accumulation taking place- getting ready to bounce again
|
|
Nikolajxo1
|
21 |
7.5K |
0 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
21
|
7.5K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Short position- MSB 3rd most heavily shorted ASX o share
|
|
Nikolajxo1
|
29 |
12K |
2 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
29
|
12K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Short position- MSB 3rd most heavily shorted ASX o share
|
|
Nikolajxo1
|
29 |
12K |
5 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
29
|
12K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
0 |
16/01/21 |
16/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
3 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
Nikolajxo1
|
10K |
3.0M |
1 |
15/01/21 |
15/01/21 |
ASX - By Stock
|
10K
|
3.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
9 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
1 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
7 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
1 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
2 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
1 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
0 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Rexlemestrocel Reduces Heart Attacks/Strokes/CV Death in CHF
|
|
Nikolajxo1
|
763 |
324K |
9 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
763
|
324K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Attention: Dr. Silviu Itescu
|
|
Nikolajxo1
|
43 |
20K |
2 |
02/01/21 |
02/01/21 |
ASX - By Stock
|
43
|
20K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - A new year 2021
|
|
Nikolajxo1
|
9 |
4.0K |
3 |
01/01/21 |
01/01/21 |
ASX - By Stock
|
9
|
4.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - A new year 2021
|
|
Nikolajxo1
|
9 |
4.0K |
3 |
01/01/21 |
01/01/21 |
ASX - By Stock
|
9
|
4.0K
|
3
|
|
ASX - By Stock
|
MSB |
MSB Trading - A new year 2021
|
|
Nikolajxo1
|
9 |
4.0K |
3 |
01/01/21 |
01/01/21 |
ASX - By Stock
|
9
|
4.0K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
Nikolajxo1
|
13K |
5.0M |
0 |
29/12/20 |
29/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
CHF - The real phase 3 headlines
|
|
Nikolajxo1
|
147 |
73K |
1 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
147
|
73K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
CHF - The real phase 3 headlines
|
|
Nikolajxo1
|
147 |
73K |
3 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
147
|
73K
|
3
|
|
ASX - By Stock
|
MSB |
Back pain read out - what are your thoughts?
|
|
Nikolajxo1
|
9 |
3.8K |
0 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
9
|
3.8K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
Nikolajxo1
|
317 |
157K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
317
|
157K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
Nikolajxo1
|
317 |
157K |
0 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
317
|
157K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Guess the reason for MSB Trading Halt
|
|
Nikolajxo1
|
317 |
157K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
317
|
157K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading halt
|
|
Nikolajxo1
|
796 |
395K |
1 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
796
|
395K
|
1
|
|